Aegerion Pharmaceuticals, Inc. Logo
  • Contact Us
  • |
  • 1.617.500.7867
  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Dividend History
    • Analyst Coverage
    • Ownership Profile
  • Investor FAQs
  • Contact Us

NASDAQ: AEGR
Price:
14.14
Change:
- 0.19
Day High:
14.54
Day Low:
14.07
Volume:
44,400
4:00 PM ET on May 18, 2012
Delayed at least 20 minutes.
Provided by eSignal.
Shareholder Tools
BriefcaseShareholder Briefcase Printed MaterialsPrinted Materials Email AlertsEmail Alerts Download CenterDownload Library snapshotSnapshot RSSRSS News Feeds
Search Investor Relations
Print   Email   Share
Share this on: Close window
delicious delicious
Digg Digg
Facebook Facebook
LinkedIn LinkedIn
Twitter Twitter
Yahoo Buzz Yahoo! Buzz
What is this?

Quarterly Results

  
2012
Hide / Show
First Quarter 2012
Press release Aegerion Pharmaceuticals Announces First Quarter 2012 Financial Results
Webcast Q1 2012 Earnings Conference Call
2011
Hide / Show
Fourth Quarter 2011
Press release Aegerion Pharmaceuticals Announces Fourth-Quarter and Full-Year 2011 Financial Results
Webcast Q4 2011 Earnings Conference Call
Hide / Show
Third Quarter 2011
Press release Aegerion Pharmaceuticals Announces Third-Quarter 2011 Financial Results
SEC filing Form 10-Q
Hide / Show
Second Quarter 2011
Press release Aegerion Pharmaceuticals Announces Second-Quarter 2011 Financial Results
SEC filing Form 10-Q
Hide / Show
First Quarter 2011
Press release Aegerion Pharmaceuticals Announces First-Quarter 2011 Financial Results
SEC filing Form 10-Q
2010
Hide / Show
Fourth Quarter 2010
Press release Aegerion Pharmaceuticals Announces Fourth-Quarter and Year-End 2010 Financial Results
SEC filing Form 10-K
Hide / Show
Third Quarter 2010
Press release Aegerion Pharmaceuticals Announces Third-Quarter 2010 Financial Results
SEC filing Form 10-Q
Add to Briefcase = add file to Briefcase

© 2011 Aegerion Pharmaceuticals, Inc. All rights reserved

  • Terms of use
  • |
  • Request Info
  • |
  • Site Map